Clinical trial
Escitalopram in Schizophrenia in OCD- Open Label Study
NCT00456937 · BeerYaakov Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00456937 |
|---|---|
| Title | Escitalopram in Schizophrenia in OCD- Open Label Study |
| Official title | Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study |
| Lead sponsor | BeerYaakov Mental Health Center, Other |
| Collaborators | Lundbeck Israel Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Escitalopram |
| Enrollment | 15 |
| Start date | Jul 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Apr 5, 2007 |
| Last update posted | Jan 27, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: